These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 12444552)

  • 1. Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1.
    Lanzi C; Cassinelli G; Cuccuru G; Zaffaroni N; Supino R; Vignati S; Zanchi C; Yamamoto M; Zunino F
    Cell Mol Life Sci; 2003 Jul; 60(7):1449-59. PubMed ID: 12943231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose ionizing radiation-induced RET/PTC1 rearrangement via the non-homologous end joining pathway to drive thyroid cancer.
    Liu Y; Zhu J; Zhou S; Hou Y; Yan Z; Ao X; Wang P; Zhou L; Chen H; Liang X; Guan H; Gao S; Xie D; Gu Y; Zhou PK
    MedComm (2020); 2024 Aug; 5(8):e690. PubMed ID: 39135916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.
    Choi HR; Kim K
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models.
    Jeon MJ; Haugen BR
    Endocrinol Metab (Seoul); 2022 Dec; 37(6):830-838. PubMed ID: 36604954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of thyroid cancer: A 2015 update.
    Kirschner LS; Qamri Z; Kari S; Ashtekar A
    Mol Cell Endocrinol; 2016 Feb; 421():18-27. PubMed ID: 26123589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cancer: pathogenesis and targeted therapy.
    Liebner DA; Shah MH
    Ther Adv Endocrinol Metab; 2011 Oct; 2(5):173-95. PubMed ID: 23148184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression.
    Balogh K; Asa SL; Zheng L; Cassol C; Cheng S; Ezzat S
    Oncogene; 2012 Sep; 31(36):4012-21. PubMed ID: 22158039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.
    Goncalves AP; Videira A; Maximo V; Soares P
    J Biosci; 2011 Sep; 36(4):639-48. PubMed ID: 21857110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of endocrine tumours.
    Jones GN; Manchanda PK; Pringle DR; Zhang M; Kirschner LS
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):451-60. PubMed ID: 20833336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.
    Melillo RM; Castellone MD; Guarino V; De Falco V; Cirafici AM; Salvatore G; Caiazzo F; Basolo F; Giannini R; Kruhoffer M; Orntoft T; Fusco A; Santoro M
    J Clin Invest; 2005 Apr; 115(4):1068-81. PubMed ID: 15761501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.
    Celetti A; Cerrato A; Merolla F; Vitagliano D; Vecchio G; Grieco M
    Oncogene; 2004 Jan; 23(1):109-21. PubMed ID: 14712216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis].
    Voskoboĭnyk LH
    Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors predisposing to the development of papillary thyroid cancer].
    Puzianowska-Kuźnicka M; Pietrzak M
    Endokrynol Pol; 2005; 56(3):339-45. PubMed ID: 16350729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
    Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
    Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
    Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
    Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.